Jenifer Cynthia R A, Srinivasan Sivapragasam, Vijay V K, Saravanan Deepshika, Balaji Saravana, Navarasu M
Department of Periodontology, Sri Venkateswara Dental College and Hospital, Chennai, Tamil Nadu, India.
Department of Periodontology, Rajah Muthiah Dental College and Hospital, Chidambaram, Tamil Nadu, India.
J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S955-S958. doi: 10.4103/jpbs.jpbs_746_21. Epub 2022 Jul 13.
The present study aimed to estimate the serum procalcitonin (PCT) levels in periodontally healthy individuals and chronic periodontitis patients with Type II diabetes mellitus (DM).
Forty-five male subjects aged 25-60 years were enrolled in the study and grouped as Group I (healthy), Group II (chronic periodontitis), and Group III (chronic periodontitis with Type II DM). Clinical parameters (dental plaque scores, bleeding scores, probing pocket depth, and loss of attachment) and glycemic parameters (random blood sugar and glycated hemoglobin levels) were recorded. Serum procalcitonin levels were analyzed using Raybio Human Procalcitonin Enzyme-Linked Immunosorbent Assay kit using the sandwich technique. All the data obtained were tabulated and analyzed using SYSTAT 12 statistical software. Kruskal-Wallis test was applied to compare the mean scores between the three study groups, and Spearman's ρ correlation coefficient was used to find out the association.
Serum procalcitonin levels were markedly increased in periodontitis group when compared to the healthy group. The mean serum levels of procalcitonin in Group I, Group II, and Group III were 22.52 pg/ml, 64.23 pg/ml, and 185.86 pg/ml, respectively. The variation in the procalcitonin levels was statistically significant at < 0.001.
The expression of procalcitonin in serum was increased to eightfold in the periodontitis group with diabetes in comparison to the healthy group, which shows that periodontal disease can cause the release of procalcitonin.
本研究旨在评估牙周健康个体以及患有2型糖尿病(DM)的慢性牙周炎患者的血清降钙素原(PCT)水平。
45名年龄在25 - 60岁的男性受试者参与了本研究,并被分为三组:第一组(健康组)、第二组(慢性牙周炎组)和第三组(患有2型糖尿病的慢性牙周炎组)。记录临床参数(牙菌斑评分、出血评分、探诊深度和附着丧失)和血糖参数(随机血糖和糖化血红蛋白水平)。使用Raybio人降钙素原酶联免疫吸附测定试剂盒,采用夹心技术分析血清降钙素原水平。所有获得的数据进行列表,并使用SYSTAT 12统计软件进行分析。应用Kruskal - Wallis检验比较三个研究组之间的平均得分,并使用Spearman等级相关系数来确定相关性。
与健康组相比,牙周炎组的血清降钙素原水平显著升高。第一组、第二组和第三组的血清降钙素原平均水平分别为22.52 pg/ml、64.23 pg/ml和185.86 pg/ml。降钙素原水平的差异在<0.001时具有统计学意义。
与健康组相比,糖尿病伴牙周炎组血清中降钙素原的表达增加了八倍,这表明牙周疾病可导致降钙素原的释放。